logo
  Join        Login             Stock Quote

VIVUS (VVUS) Shares Jump After Qsymia Study Results

 February 01, 2013 07:57 AM
 


(By Balachander) VIVUS Inc. (NASDAQ: VVUS) said a study concluded its weight-loss drug Qsymia significantly improved multiple cardiovascular disease risk factors, and its shares jumped 6.11 percent in premarket trading on Friday.

The biopharmaceutical company said patients with hypertension or high cholesterol treated with Qsymia for one year experienced significant weight loss and clinically meaningful improvements in their underlying cardiovascular risk factors.

Qsymia was approved by the U.S. Food and Drug Administration (FDA) in July 2012, with sales launched on September 17.

In the study, the company said, Qsymia produced significantly greater dose-related mean percentage weight loss compared with placebo in the subgroups of participants with dyslipidemia and those with hypertension.

[Related -Aetna Inc (AET) & Coventry Health Care, Inc. (CVH): Game Changer]

The improvements were significantly greater among patients who lost 10% or more of their starting weight, VIVUS said.

In the four-week period ended Oct. 26, Qsymia prescriptions shipped was 5,394, a regulatory filing showed.

Health insurer Aetna (NYSE: AET) had late last year decided to provide coverage for Qsymia.

Obesity is a chronic condition defined by having excess body fat. According to the World Health Organization and CDC, more than 500 million people worldwide and roughly one-third of American adults are obese.

[Related -Aetna Inc (AET): Fundamental Stock Research Analysis]

The stock, which has been trading in the 52-week between $9.86 and $31.21, closed at $12.11 on Thursday.

iOnTheMarket Premium
Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article imageFord Motor Company (F): A long Road to Deutsche Bank’s $19 Target

Ford Motor Company (NYSE:F) is going the right way on a one way street where most everybody else is driving read on...

article imageCitigroup Inc (C) Q1 Earnings Preview: Too Many Parts Heading South

Citigroup Inc (NYSE:C) will issue its first quarter results via press release at approximately 8 a.m. (ET) read on...

article imageFacebook Inc (FB): You Might Not Like It Today, But You’ll Like It Tomorrow

Do you honestly want to invest in stocks right now? It sure looks like the bull market is at least on read on...

article imageJPMorgan Chase & Co. (JPM) Q1 Earnings Preview: Regulation Costs To Trim Guidance?

JPMorgan Chase & Co. (NYSE:JPM) will host a conference call to review first quarter 2014 financial results read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.